FDA Releases Draft Guidance on Monoclonal Antibodies in Drug Manufacturing

Summary

The US Food and Drug Administration (FDA) has published a draft guidance document outlining recommendations for the use of monoclonal antibodies as reagents in the production of pharmaceuticals, covering various regulatory applications and requirements.